rhodioloside has been researched along with phenolsulfonphthalein in 1 studies
| Studies (rhodioloside) | Trials (rhodioloside) | Recent Studies (post-2010) (rhodioloside) | Studies (phenolsulfonphthalein) | Trials (phenolsulfonphthalein) | Recent Studies (post-2010) (phenolsulfonphthalein) |
|---|---|---|---|---|---|
| 621 | 2 | 519 | 999 | 27 | 163 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, J; He, Y; Huang, S; Kasim, V; Liu, C; Marcelina, O; Miyagishi, M; Nugrahaningrum, DA; Wang, G; Wu, S; Zou, M | 1 |
1 other study(ies) available for rhodioloside and phenolsulfonphthalein
| Article | Year |
|---|---|
Discovery of Salidroside-Derivated Glycoside Analogues as Novel Angiogenesis Agents to Treat Diabetic Hind Limb Ischemia.
Topics: Angiogenesis Inducing Agents; Animals; Diabetes Mellitus, Experimental; Glucosides; Glycosides; Hindlimb; Ischemia; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Phenols; Rats; Rats, Sprague-Dawley | 2022 |